Browsing by Author Fei, Li

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 7 of 7
Issue Date Title Author(s)
2011 Empirically-Sourced Mechanical Behaviors of Pneumatic Artificial Muscles for Compensation-Based Controls Fei, Li;Yu, Wang;Heting, Tong;Han, Ray P. S.
2016 Hazard degree assessment of coastal erosion at Tianlongsi adjacent sandy coast Wen, Shiyong;Fengshou, Zhang;Xiang, Wang;Zizhu, Wang;Fei, Li;Fei, Wang;Xinxin, Wang;Xu, Xuegong
15-Nov-2022 Is the 2nd Generation Tyrosine Kinase-Inhibitor a Better Initial Therapy Than Imatinib in Persons with Chronic Myeloid Leukemia Presenting in Accelerated Phase: A Multicenter Retrospective Study Yang, Sen;Zhang, Xiaoshuai;Zhang, Yanli;Du, Xin;Weng, Jianyu;Zhu, Huanling;Pan, Ling;Yang, Yun-fan;Meng, Li;Liu, Zhenfang;Liu, Xiaoli;Xu, Na;Chen, Chunyan;Wang, Xiaodong;Liang, Rong;Huang, Jian;Li, Guohui;Liu, Chunshui;Lin, Hai;Hu, Jianda;Fei, Li;Liu, Bingcheng;Li, Weiming;Liu, Zhuogang;Yang, Wei;Huang, Xiao Jun;Jiang, Qian
15-Nov-2022 A Predictive Scoring System for Therapy Failure in Persons with Chronic Myeloid Leukemia Receiving Initial a Second-Generation Tyrosine Kinase Inhibitor Therapy Zhang, Xiaoshuai;Liu, Bingcheng;Huang, Jian;Zhang, Gongli;Liu, Xiaoli;Xu, Na;Li, Weiming;Du, Xin;Weng, Jianyu;Lin, Hai;Liang, Rong;Chen, Chunyan;Zhu, Huanling;Pan, Ling;Yang, Yun-fan;Wang, Xiaodong;Li, Guohui;Liu, Zhuogang;Liu, Zhenfang;Hu, Jianda;Liu, Chunshui;Fei, Li;Yang, Wei;Meng, Li;Gale, Robert Peter;Huang, Xiao Jun;Jiang, Qian
15-Nov-2022 Study of the Anti-Btla Antibody Tifcemalimab As a Single Agent or in Combination with Toripalimab in Relapsed/Refractory Lymphomas Ma, Jun;Song, Yuqin;Xie, Yan;Zhang, Hui-Lai;Shuang, Yuerong;Peng, Zhigang;Fei, Li;Huang, Yunhong;Zhao, Weili;Huang, Wenrong;Pan, Yali;Liu, Mingying;Ran, Feiwu;Feng, Hui;Yao, Sheng;Keegan, Patricia;Zou, Jianjun;Zhu, Jun
15-Nov-2022 Subjects with Chronic Myeloid Leukemia Identified As Intermediate- or High-Risk Subjects Using the Imatinib Therapy Failure (IMTF) Model Benefit from Initial Therapy with a Second-Generation Tyrosine Kinase Inhibitor Zhang, Xiaoshuai;Liu, Bingcheng;Huang, Jian;Zhang, Gongli;Liu, Xiaoli;Xu, Na;Li, Weiming;Du, Xin;Weng, Jianyu;Lin, Hai;Liang, Rong;Chen, Chunyan;Zhu, Huanling;Pan, Ling;Yang, Yun-fan;Wang, Xiaodong;Li, Guohui;Liu, Zhuogang;Liu, Zhenfang;Hu, Jianda;Liu, Chunshui;Fei, Li;Yang, Wei;Meng, Li;Gale, Robert Peter;Huang, Xiao Jun;Jiang, Qian
15-Nov-2022 Validation and Use of Predictive Scoring Systems for Molecular Responses in 5,203 Persons with Chronic Myeloid Leukemia Zhang, Xiaoshuai;Liu, Bingcheng;Huang, Jian;Zhang, Gongli;Liu, Xiaoli;Xu, Na;Li, Weiming;Du, Xin;Weng, Jianyu;Lin, Hai;Liang, Rong;Chen, Chunyan;Zhu, Huanling;Pan, Ling;Yang, Yunfan;Wang, Xiaodong;Li, Guohui;Liu, Zhuogang;Liu, Zhenfang;Hu, Jianda;Liu, Chunshui;Fei, Li;Yang, Wei;Meng, Li;Gale, Robert Peter;Huang, Xiao Jun;Jiang, Qian